Pharma & Biotech

In a surprising turn of events, Danish pharmaceutical giant Novo Nordisk has withdrawn from the high-stakes bidding competition for US...

After an extended period of decline, Bristol-Myers Squibb shares are showing signs of a potential turnaround. A combination of robust...

In the competitive landscape of biotechnology, two giants command significant attention: Vertex Pharmaceuticals and Regeneron Pharmaceuticals. Both companies have established...

Investors are closely monitoring Bayer as the company approaches the release of its third-quarter financial report this Wednesday. The pharmaceutical...

Sangamo Therapeutics finds itself navigating perilous financial waters, with its stock experiencing a dramatic 21% decline following disappointing quarterly results...

Viking Therapeutics has captured significant market attention following the release of impressive clinical trial results for its obesity treatment candidate...

The pharmaceutical sector is witnessing unprecedented excitement around innovative obesity treatments, with Eli Lilly positioned squarely at the epicenter of...

A significant trade barrier has been partially dismantled for genomics leader Illumina. After months of restricted access, Chinese authorities have...

Shares of animal health company Zoetis experienced a dramatic sell-off on November 4th, plummeting 13.78 percent to establish a new...

Geron Corporation witnessed a significant sell-off in its stock price on Friday, with shares declining by more than 9%. This...